Tylenol maker Kenvue to cut 4% jobs, ... Kenvue's stock is down 11% so far this year, and 13% from its IPO price since listing in May last year. Shares were up 2.3% in premarket trading on Tuesday.
Volume fell by 3.1% due to the lapping of one-time retailer inventory re-builds in the first quarter of 2023, as well as the impact of retailer inventory reduction in the first quarter of 2024, which ...
Lucid Group Inc. will eliminate about 400 jobs in the coming months, the latest move by an electric-vehicle maker to cut costs in a dramatically slowing market for plug-in cars. The reductions ...
SYDNEY—Australian telecommunications company Telstra TLS0.00%increase; green up pointing triangle plans to cut jobs at its troubled enterprise unit as part of a continuing strategic review ...
, opens new tab announced on Tuesday that it plans to cut hundreds of jobs at its corporate headquarters and relocate a majority of its U.S. and Canada-based remote workforce to three offices, a ...
, opens new tab will cut 4% of its global workforce amid investments to grow its key brands, the Tylenol and Band-Aid maker said on Tuesday, as it topped beat Wall Street estimates for first ...
Kenvue Inc.'s stock jumped 2% early Tuesday, after the consumer health business that was spun out of Johnson & Johnson last year posted better-than-expected first-quarter earnings and announced ...
Kenvue's skin health and beauty segment, consisting of brands including Neutrogena and Clean & Clear, recorded a 5% drop in first-quarter sales to $1.05 billion, but largely in line with estimates.